Are 'Reverse Payments' Becoming More Reasonable?
Over the last several years, competition between branded and generic drugs have become an increasingly important focus for U.S. antitrust authorities and private antitrust plaintiffs....To view the full article, register now.
Already a subscriber? Click here to view full article